- Home
- REAL vs PRQR Comparison
REAL vs PRQR Comparison
Compare REAL & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- PRQR
- Stock Information
- Founded
- REAL 2011
- PRQR 2012
- Country
- REAL United States
- PRQR Netherlands
- Employees
- REAL N/A
- PRQR N/A
- Industry
- REAL Other Specialty Stores
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- REAL Consumer Discretionary
- PRQR Health Care
- Exchange
- REAL Nasdaq
- PRQR Nasdaq
- Market Cap
- REAL 982.8M
- PRQR 309.5M
- IPO Year
- REAL 2019
- PRQR 2014
- Fundamental
- Price
- REAL $10.99
- PRQR $2.68
- Analyst Decision
- REAL Buy
- PRQR Strong Buy
- Analyst Count
- REAL 6
- PRQR 5
- Target Price
- REAL $7.04
- PRQR $7.60
- AVG Volume (30 Days)
- REAL 3.9M
- PRQR 605.4K
- Earning Date
- REAL 11-04-2024
- PRQR 11-07-2024
- Dividend Yield
- REAL N/A
- PRQR N/A
- EPS Growth
- REAL N/A
- PRQR N/A
- EPS
- REAL N/A
- PRQR N/A
- Revenue
- REAL $579,862,000.00
- PRQR $20,506,357.00
- Revenue This Year
- REAL $11.26
- PRQR $235.11
- Revenue Next Year
- REAL $8.81
- PRQR N/A
- P/E Ratio
- REAL N/A
- PRQR N/A
- Revenue Growth
- REAL 2.52
- PRQR 306.68
- 52 Week Low
- REAL $1.52
- PRQR $1.61
- 52 Week High
- REAL $11.08
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- REAL 80.68
- PRQR 38.34
- Support Level
- REAL $9.00
- PRQR $2.48
- Resistance Level
- REAL $9.73
- PRQR $2.83
- Average True Range (ATR)
- REAL 0.84
- PRQR 0.28
- MACD
- REAL 0.07
- PRQR -0.06
- Stochastic Oscillator
- REAL 98.25
- PRQR 28.78
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.